CD151, CD151 molecule (Raph blood group), 977

N. diseases: 101; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.080 Biomarker phenotype BEFREE Anti-tumour active immunity primed by peptides from CD151 may be an effective and safe approach to suppress cancer progression. 31668880 2019
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.080 Biomarker phenotype BEFREE Previous studies <i>in vivo</i>, <i>in vitro</i> and in the clinic have demonstrated that CD151 is involved in tumor progression at different levels through interaction with integrins, growth factor receptors and matrix metalloproteinases. 29391901 2018
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.080 Biomarker phenotype BEFREE Tspan8-/CD151-TEX play central roles in tumor progression. 30541597 2018
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.080 Biomarker phenotype BEFREE CD151 is involved in cell adhesion, motility and cancer progression due to formation of complexes with laminin-binding integrins and regulation of growth factor receptors function (e.g.HGFR, TGFβR, EGFR). 28291843 2017
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.080 Biomarker phenotype BEFREE Tetraspanin CD151 and its associated α3β1 integrin have been implicated in facilitating tumor progression across multiple cancer types. 26377974 2015
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.080 Biomarker phenotype BEFREE We demonstrate that CD151 can regulate tumor cell migration without direct integrin binding and that integrin-free CD151 (CD151(free)) correlates clinically with tumor progression and metastasis. 24220242 2014
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.080 Biomarker phenotype BEFREE Tetraspanins including CD9, CD37, CD63, and CD151 are linked to cellular adhesion, cell differentiation, migration, carcinogenesis, and tumor progression. 20118909 2010
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.080 Biomarker phenotype BEFREE In a prototypical basal-like mammary tumor line, CD151 ablation notably delayed tumor progression in ectopic and orthotopic xenograft models. 18451146 2008